SCIENTIFIC BACKGROUND

APOB, LDLR, LDLRAP1, PCSK9

Scientific Background

Familial hypercholesterolemia (FH, type IIa according to the Fredrickson classification) is one of the most common monogenic diseases with a frequency of 1:200 to 1:500. The classical form of FH follows an autosomal dominant inheritance pattern and is characterized by an increase in serum LDL-cholesterol (LDL-C) (in heterozygotes LDL-C ranges from 190-450 mg/dl and in homozygotes it is >400 mg/dl). Pathogenic variants in three genes that influence the function of the LDL receptor are described as the cause of autosomal dominant FH. The most common cause (74% of cases) is pathogenic variants in the LDLR gene, but genetic defects of the apolipoprotein B-100 (APOB gene, 2-7%) or the protease PCSK9 gene (<3%) can also be causative.

 

The LDL-C concentration in the blood is regulated by the interaction of LDL with the LDL receptor (Apo B/E- or LDLR). The proprotein convertase subtilisin/kexin type 9 (pcsk9) is involved in the degradation of the LDL receptor and thus also influences the LDL-C concentration. The FH phenotype includes skin and tendon xanthomas as well as arcus lipoides, which can occur in childhood in homozygous carriers of the autosomal dominant form. If left untreated, homozygous FH often leads to death before the age of 30 due to myocardial infarction; in heterozygous patients, symptomatic coronary artery disease is likely before the age of 50. The detection of variants in the causative genes may justify more intensive therapeutic measures (e.g., lipid apheresis) if drug treatment is not sufficient.

 

If a so-called gain-of-function variant in the PCSK9 gene is detected in a patient, treatment with alirocumab and evolocumab, which were approved in Europe in 2015, may be considered as a therapy. These monoclonal antibodies reduce the number of pcsk9 molecules, which leads to an increase in the availability of LDL receptors on the surface of hepatocytes and a significant reduction in LDL cholesterol in plasma.

 

In rare cases, familial hypercholesterolemia has an autosomal recessive inheritance pattern. Pathogenic variants in the LDLRAP1 gene (LDL adaptor protein) have been identified that are associated with the autosomal recessive form of FH. The treatment of homozygous carriers of LDLRAP1 variants corresponds to that of LDLR variants. Pathogenic APOB gene variants (FLDB) can also cause clinical symptoms of FH.

 

References

Lee et al. 2019, Lipids in Health and Disease 18:95 / Ramasamy 2016, Clin Chim Acta 454:143 / Schulze-Bahr et al. 2015, Dtsch Med Wochenschr 140:1538 / Hopkins et al. 2015, Circ Cardiovasc Genetic 8:823 / Gabcova-Balaziova et al. 2015, Endocr Regul 49:164 / Goldstein et al. in Scriver et al. 2001 (eds): The Metabolic and Molecular Bases of Inherited Disease, 8th Ed, Chapter 120

GENES

APOB, LDLR, LDLRAP1, PCSK9
How to order

LATEST ARTICLES

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more

Aneuploidies, such as translocations, whole or segmental chromosomal duplications, and deletions, are examples of chromosomal abnormalities that are ...

Read more